Myung-il Chung, CEO of Gunsei Bio Tec Inc.Reading Precision Nutrition Through Hair: Building the Future of Personalized Healthcare
De la Academia a la ConsultoríaEl Viaje Estratégico de Byung-Ik Jung como Anderson Consulting Partner
Empoderando a Innovadores Glocales a través de la Perspectiva Global y la Acción LocalLa visión del Decano Joon-Ki Han para Busan International College
Myung-il Chung, CEO of Gunsei Bio Tec Inc.Reading Precision Nutrition Through Hair: Building the Future of Personalized Healthcare
The Atlantic-Cape Out of the Darkness Walk Surpassed $1 Million Raised Since 2018 with Hard Rock Atlantic City’s Support for Suicide Prevention
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight
TEQUILA DON JULIO PARTNERS WITH MEXICO’S ACCLAIMED PANADERÍA ROSETTA TO BRING THE SPIRIT OF DÍA DE MUERTOS TO THE WORLD
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
Level Education Group Acquires Triad to Transform the Educational and Professional Pathway for Behavioral and Mental Health Professionals
Results published in Neurology highlight a 95% reduction in risk of death with pyrimidine nucleos(t)ide therapy in patients with thymidine kinase 2 deficiency (TK2d)